Role of transforming growth factor beta 1 in induction of colon carcinoma differentiation by hexamethylene bisacetamide.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Cancer Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 2295065
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of intestinal epithelial cell growth by transforming growth factor type beta.

  1989cited by this paper
• Peptide growth factors are multifunctional

  1988cited by this paper
• Growth modulation of mouse keratinocytes by transforming growth factors.

  1988cited by this paper
• New chemotherapeutic drug sensitivity assay for colon carcinomas in monolayer culture.

  1988cited by this paper
• Heterogeneous responses of human colon carcinomas to hexamethylene bisacetamide.

  1988cited by this paper
• Phase I trial and clinical pharmacological evaluation of hexamethylene bisacetamide administration by ten-day continuous intravenous infusion at twenty-eight-day intervals.

  1988cited by this paper
• Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor beta

  1988cited by this paper
• pl Bl5: A cDNA Clone of the Rat mRNA Encoding Cyclophilin

  1988cited by this paper
• Loss of growth factor dependence and conversion of transforming growth factor-beta 1 inhibition to stimulation in metastatic H-ras-transformed murine fibroblasts.

  1988cited by this paper
• Transforming growth factor-beta 2: cDNA cloning and sequence analysis.

  1988cited by this paper
• Characterization of the inhibitory effects of transforming growth factor-beta on a human colon carcinoma cell line.

  1987cited by this paper
• Reciprocal effects of epidermal growth factor and transforming growth factor beta on the anchorage-dependent and -independent growth of A431 epidermoid carcinoma cells.

  1987cited by this paper
• The TGF-beta family of growth and differentiation factors.

  1987cited by this paper
• Phase I clinical and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered as a five-day continuous infusion.

  1987cited by this paper
• Transforming growth factor β regulation of cell proliferation

  1987cited by this paper
• Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta.

  1987cited by this paper
• Induction of transformed cells to terminal differentiation and the modulation of gene expression.

  1987cited by this paper
• Absorptive and mucus-secreting subclones isolated from a multipotent intestinal cell line (HT-29) provide new models for cell polarity and terminal differentiation

  1987cited by this paper
• Regulation of proliferation and differentiation of respiratory tract epithelial cells by TGF beta.

  1986cited by this paper
• Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity.

  1986cited by this paper
• The murine transforming growth factor-beta precursor.

  1986cited by this paper
• Production of transforming growth factors by human colon cancer lines.

  1986cited by this paper
• Type beta transforming growth factor is an inhibitor of myogenic differentiation.

  1986cited by this paper
• Transforming growth factor-beta. A very potent inhibitor of myoblast differentiation, identical to the differentiation inhibitor secreted by Buffalo rat liver cells.

  1986cited by this paper
• Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells.

  1986cited by this paper
• Purification and biological properties of type beta transforming growth factor from mouse transformed cells.

  1986cited by this paper
• Ultrastructural evidence of dimethylformamide‐induced differentiation of cultured human colon carcinoma cells increased expression of desmosomes

  1985cited by this paper
• Human transforming growth factor-alpha: precursor structure and expression in E. coli.

  1984cited by this paper
• Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate.

  1984cited by this paper
• Effects of sodium butyrate, dimethyl sulfoxide, and retinoic acid on glycolipids of human rectal adenocarcinoma cells.

  1984cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper
• Inhibition of the growth of human colon cancer xenografts by polar solvents.

  1982cited by this paper
• Maturation‐induction of tumor cells using a human colon carcinoma model

  1980cited by this paper
• Effects of sodium butyrate and dimethylsulfoxide on biochemical properties of human colon cancer cells

  1980cited by this paper
• A new group of potent inducers of differentiation in murine erythroleukemia cells.

  1976cited by this paper
• Cell proliferation in rectal carcinoma and rectal mucosa. A stathmokinetic study.

  1973cited by this paper

• HOXD13-mediated immune crosstalk between cancer cells and tumor-associated macrophages drives colorectal cancer progression

  2026cites this paper
• The Therapeutic Strategies Based on Cytokines in The Treatment of Colorectal Cancer

  2024cites this paper
• TGFβ and the Tumor Microenvironment in Colorectal Cancer

  2023cites this paper
• Navigating Molecular Pathways: An Update on Drugs in Colorectal Cancer Treatment.

  2023cites this paper
• Non-collagenous extracellular matrix protein dermatopontin may play a role as another component of transforming growth factor-β signaling pathway in colon carcinogenesis

  2021cites this paper
• Loss of Hyaluronan and Proteoglycan Link Protein-1 Induces Tumorigenesis in Colorectal Cancer

  2021cites this paper
• Genetic variation of TGF-ΒR2 as a protective genotype for the development of colorectal cancer in men

  2021cites this paper
• Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer

  2020cites this paper
• PEITC inhibits the invasion and migration of colorectal cancer cells by blocking TGF-β-induced EMT.

  2020cites this paper
• TAGLN and High-mobility Group AT-Hook 2 (HMGA2) Complex Regulates TGF-β-induced Colorectal Cancer Metastasis

  2020cites this paper
• Calycosin suppresses TGF-β-induced epithelial-to-mesenchymal transition and migration by upregulating BATF2 to target PAI-1 via the Wnt and PI3K/Akt signaling pathways in colorectal cancer cells

  2019cites this paper
• The Role of TGF-β and Its Receptors in Gastrointestinal Cancers

  2019cites this paper
• TGF-β signaling in liver and gastrointestinal cancers.

  2016cites this paper
• Nox4-generated ROS Regulate TGF-β1-induced Motility of Colon Cancer Cells through the Low Molecular Weight Protein Tyrosine Phosphatase-Rho Signaling Pathway

  2015cites this paper
• Reconstitution of TGFBR2-Mediated Signaling Causes Upregulation of GDF-15 in HCT116 Colorectal Cancer Cells

  2015cites this paper
• Colon cancer bears overexpression of OTUB1.

  2014cites this paper
• Boswellia Serrata Suppresses Colorectal Carcinogenesis: In-vitro and In-vivo Studies

  2014cites this paper
• MicroRNA‐200b Stimulates Tumour Growth in TGFBR2‐Null Colorectal Cancers by Negatively Regulating p27/kip1

  2014cites this paper
• Clinical applications of molecular profiling in colorectal cancer: Review of the literature

  2013cites this paper
• Signalling tissue renewal and crypt survival in the human colonic epithelium and Barrett's oesophagus

  2013cites this paper
• Possible therapeutic mechanisms of turmeric against colorectal cancer induced by N-methylnitrosourea in experimental models

  2013cites this paper
• ANTITUMOR EFFICACY OF BOSWELLIA SERRATA EXTRACT IN MANAGEMENT OF COLON CANCER INDUCED IN EXPERIMENTAL ANIMAL

  2013cites this paper
• Tropomyosin receptor kinases B and C are tumor progressive and metastatic marker in colorectal carcinoma.

  2013cites this paper
• A proteomic and genomic investigation into the role of lamin A in colorectal cancer cell motility

  2012cites this paper
• MEMBRANE EFFECTS OF SEX HORMONES ON GROWTH

  2012cites this paper
• TGF-beta signalling in colon carcinogenesis.

  2012cites this paper
• Membrane effects of sex hormones on growth plate chondrocytes

  2012influential citation
• Diversity of axin in signaling pathways and its relation to colorectal cancer

  2011cites this paper
• Identification of Genes Differentially Expressed in Human Rectal Carcinoma with Microarray Analysis

  2010cites this paper
• RUNX3 Inhibits Cell Proliferation and Induces Apoptosis by TGF-β-Dependent and -Independent Mechanisms in Human Colon Carcinoma Cells

  2009cites this paper
• Role of transforming growth factor beta in colorectal cancer.

  2009cites this paper
• The Genomics of Colorectal Cancer: State of the Art

  2008cites this paper
• TGF-beta signaling alterations and susceptibility to colorectal cancer.

  2007cites this paper
• TGF-β signaling alterations and susceptibility to colorectal cancer

  2007cites this paper
• 2 β and 1 β Cancer Cell Lines to Transforming Growth Factors Responsiveness of Three Newly Established Human Colorectal

  2006cites this paper
• TGF-β Signaling in Colon Cancer Cells

  2005cites this paper
• TGF-beta signaling in colon cancer cells.

  2005cites this paper
• Up-Regulation of Transforming Growth Factor a Expression by Transforming Growth Factor fl , Epidermal Growth Factor , and N , N-Dimethylformamide in Human Colon Carcinoma Cells 1

  2005cites this paper
• Autocrine growth inhibition by transforming growth factor beta-1 (TGFbeta-1) in human neuroendocrine tumour cells.

  2003cites this paper
• Autocrine growth inhibition by transforming growth factor β-1 (TGFβ-1) in human neuroendocrine tumour cells

  2003cites this paper
• Transforming growth factor beta 1 induces proliferation in colon carcinoma cells by Ras-dependent, smad-independent down-regulation of p21cip1.

  2002cites this paper
• Decreased levels of precursor transforming growth factor beta1 in human colorectal cancer.

  2001cites this paper
• TGF‐β and colorectal carcinogenesis

  2001cites this paper
• Oncogenic Ki-ras Confers a More Aggressive Colon Cancer Phenotype through Modification of Transforming Growth Factor-β Receptor III*

  2001cites this paper
• Role of transforming growth factor beta in cancer

  2001cites this paper
• TGF-beta and colorectal carcinogenesis.

  2001cites this paper
• Multiple Autocrine Factors Including an Extracellular Matrix Protein are Required for the Proliferation and Spreading of Human Colon Carcinoma Cells In Vitro

  2000cites this paper
• Igfbp‐3 mediates TGFβ1 proliferative response in colon cancer cells

  2000cites this paper
• IGFBP-3 mediates TGF beta 1 proliferative response in colon cancer cells.

  2000cites this paper
• Ursodeoxycholic acid to inhibit the growth of hepatic metastases.

  2000cites this paper
• Transforming Growth Factor-β1 Enhances Ha-ras-induced Expression of Cyclooxygenase-2 in Intestinal Epithelial Cells via Stabilization of mRNA*

  2000cites this paper
• The role of circulating cytokines in colorectal carcinoma

  2000cites this paper
• Transforming growth factor-beta1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA.

  2000cites this paper
• Elevated serum levels of transforming growth factor-beta1 in patients with colorectal carcinoma: its association with tumor progression and its significant decrease after curative surgical resection.

  1999cites this paper
• Digested fiber from wheat bran induces cdk inhibitors which block colon epithelial cells in G1.

  1999cites this paper
• Vesnarinone and glucocorticoids cooperatively induce G1 arrest and have an anti-tumour effect on human non-small cell lung carcinoma cells grown in nude mice

  1999cites this paper
• Perturbation of EGF-induced MAP kinase activation by TGF-beta 1.

  1999cites this paper
• Transformation of intestinal epithelial cells by chronic TGF-β1 treatment results in downregulation of the type II TGF-β receptor and induction of cyclooxygenase-2

  1999cites this paper
• Growth dependency of human colon cancer xenograft on organ environment is related with their original clinical stage.

  1998cites this paper
• Short-chain fatty acids induce cell cycle inhibitors in colonocytes.

  1998cites this paper
• A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1.

  1998cites this paper
• Expression of transforming growth factor beta receptors in normal human colon and sporadic adenocarcinomas.

  1998cites this paper
• Dietary Fat and Cancer

  1997cites this paper
• Short chain fatty acid regulation of intestinal gene expression.

  1997cites this paper
• Butyrate- but not TGFβ1-induced apoptosis of colorectal adenoma cells is associated with increased expression of the differentiation markers E-cadherin and alkaline phosphatase

  1997cites this paper
• The role of growth factors in proliferation and invasion of thyroid cancer.

  1997cites this paper
• Antitumor actions of cytokines on new human papillary thyroid carcinoma cell lines.

  1996cites this paper
• Modulation effects of hexamethylene bisacetamide on growth and differentiation of cultured human malignant glioma cells.

  1996cites this paper
• Transforming growth factor-β and prostate cancer

  1995cites this paper
• Transforming growth factor-beta and prostate cancer.

  1995cites this paper
• High levels of transforming growth factor beta 1 correlate with disease progression in human colon cancer.

  1995cites this paper
• Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.

  1995cites this paper
• Inhibitors of ADP-ribosylation suppress phenotypic modulation and proliferation of smooth muscle cells cultured from rat aorta.

  1995cites this paper
• Colon carcinoma cells with inactive nm23 show increased motility and response to motility factors.

  1995cites this paper
• The role of nm23 in transforming growth factor beta 1-mediated adherence and growth arrest.

  1994cites this paper
• [Growth and invasion in differentiated thyroid carcinoma. Function of different growth factors].

  1994cites this paper
• Transforming growth factor-beta 1 is a negative regulator for differentiated thyroid cancer: studies of growth, migration, invasion, and adhesion of cultured follicular and papillary thyroid cancer cell lines.

  1994cites this paper
• The capacity for growth stimulation by TGF beta 1 seen only in advanced colon cancers cannot be ascribed to mutations in APC, DCC, p53 or ras.

  1994cites this paper
• Two different signal transduction pathways can be activated by transforming growth factor beta 1 in epithelial cells.

  1994cites this paper
• Aberrations of growth factor control in metastatic follicular thyroid cancerin vitro

  1994cites this paper
• Colon carcinoma cells switch their response to transforming growth factor beta 1 with tumor progression.

  1994cites this paper
• Transforming growth factor-beta 2 is an autocrine growth inhibitory factor for the MOSER human colon carcinoma cell line.

  1993cites this paper
• Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma.

  1993cites this paper
• The role of growth regulatory aberrations in progression of human colon carcinoma

  1993cites this paper
• Induction of markers of normal differentiation in human colon carcinoma cells by the v-rasH oncogene.

  1993cites this paper
• Localization of transforming growth factor beta isoforms in the normal murine small intestine and colon.

  1993cites this paper
• Up-regulation of transforming growth factor alpha expression by transforming growth factor beta 1, epidermal growth factor, and N,N-dimethylformamide in human colon carcinoma cells.

  1993cites this paper
• Immunocytochemical Localization ofSecreted Transforming Growth Factor- 1totheAdvancing EdgesofPrimary TumorsandtoLymphNode Metastases ofHumanMammaryCarcinoma

  1993cites this paper
• Molecular basis of tumour metastasis.

  1993cites this paper
• Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells.

  1993cites this paper
• Localization of transforming growth factor β isoforms in the normal murine small intestine and colon

  1993cites this paper
• Transforming growth factor-β2 is an autocrine growth inhibitory factor for the MOSER human colon carcinoma cell line

  1993cites this paper
• Differentiation: a suitable strategy for cancer chemotherapy?

  1993cites this paper
• Characterization of the DiFi Rectal carcinoma cell line derived from a familial adenomatous polyposis patient

  1993cites this paper
• Analysis of factors associated with the tumorigenic potential of 12 tumor clones derived from a single rat colon adenocarcinoma

  1992cites this paper
• Two roles for transforming growth factor beta 1 in colon enterocytic cell differentiation.

  1992cites this paper
• [Growth factors and intestinal cancers].

  1992cites this paper
• Expression of multi-cytokine resistance and multi-growth factor independence in advanced stage metastatic cancer. Malignant melanoma as a paradigm.

  1992cites this paper
• [Regulation by protein kinase C of TGF-beta 1 expression in cultured cells of breast adenocarcinoma].

  1992cites this paper
• Growth stimulation of a human colorectal carcinoma cell line by interleukin-1 and -6 and antagonistic effects of transforming growth factor beta 1.

  1992cites this paper